Key result
NUDT18 hydrolyzes remdesivir-TP, ribavirin-TP, and molnupiravir-TP.
Why the study?
Whether endogenous enzymes catalyze the hydrolysis of active triphosphate metabolites of remdesivir, molnupiravir, and ribavirin was unknown.
NUDT18 hydrolyzes the active triphosphate metabolites of remdesivir, molnupiravir, and ribavirin, which may limit their antiviral efficacy against SARS-CoV-2 in respiratory epithelial cells.
May limit active metabolite levels in vivo; leaves open whether NUDT18 inhibition augments antiviral efficacy in humans.
Remdesivir and molnupiravir have gained considerable interest because of their demonstrated activity against SARS-CoV-2. These antivirals are converted intracellularly to their active triphosphate forms remdesivir-TP and molnupiravir-TP. Cellular hydrolysis of these active metabolites would consequently decrease the efficiency of these drugs; however, whether endogenous enzymes that can catalyze this hydrolysis exist is unknown. Here, we tested remdesivir-TP as a substrate against a panel of human hydrolases and found that only Nudix hydrolase (NUDT) 18 catalyzed the hydrolysis of remdesivir-TP with notable activity. The k cat /K m value of NUDT18 for remdesivir-TP was determined to be 17,700 s −1 M −1 , suggesting that NUDT18-catalyzed hydrolysis of remdesivir-TP may occur in cells. Moreover, we demonstrate that the triphosphates of the antivirals ribavirin and molnupiravir are also hydrolyzed by NUDT18, albeit with lower efficiency than Remdesivir-TP. Low activity was also observed with the triphosphate forms of sofosbuvir and aciclovir. This is the first report showing that NUDT18 hydrolyzes triphosphates of nucleoside analogs of exogenous origin, suggesting that NUDT18 can act as a cellular sanitizer of modified nucleotides and may influence the antiviral efficacy of remdesivir, molnupiravir, and ribavirin. As NUDT18 is expressed in respiratory epithelial cells, it may limit the antiviral efficacy of remdesivir and molnupiravir against SARS-CoV-2 replication by decreasing the intracellular concentration of their active metabolites at their intended site of action.
No takes yet. Share an insight, caveat, or question.
Jemth et al. (2022) studied SARS-CoV-2. NUDT18 was evaluated on Hydrolysis of remdesivir-TP. Nudix hydrolase 18 (NUDT18) catalyzed the hydrolysis of remdesivir-TP with a k cat /K m value of 17,700 s−1 M−1, and also hydrolyzed the triphosphates of ribavirin and molnupiravir.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: